Latest News from ASCO in Action

Latest News from ASCO in Action

March 27, 2015

ASCO is extremely disappointed that the Senate failed to act on the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2)--legislation that would eliminate the perennial threat and uncertainty that the Sustainable Growth Rate (SGR) formula creates for physicians  and Medicare beneficiaries--before adjourning for a two-week Spring recess. Physicians across the country are now in limbo, faced with an unnecessary 21 percent cut in Medicare reimbursement when the current SGR payment patch expires next week on March 31.

March 26, 2015

"We applaud the House of Representatives for passing legislation that eliminates the Sustainable Growth Rate formula and takes a giant leap toward meaningful and urgently needed Medicare physician payment reform..." 

March 26, 2015

The U.S. House of Representatives, by an overwhelming vote of 392 to 37, passed the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2), which would eliminate the perennial threat and uncertainty that the Sustainable Growth Rate (SGR) has created for physician practices, including oncology practices, across the country. The legislation now heads to a critical vote in the U.S. Senate. 

ASCO's ACT Network

ASCO's ACT Network

ALERT CONGRESS TODAY! Use ASCO's ACT Network to contact your elected officials on important policy issues impacting cancer care. 

ASCO Issue Backgrounders

ASCO Issue Backgrounders

ASCO offers issue backgrounders to help provide an overview of the major policy issues that impact patients with cancer and the physicians who care for them. The issue backgrounders cover topics such as reimbursement, health equity, cancer research funding, and more.

Click here to read the backgrounds and help develop your understanding of cancer policy issues.

NIH Funding Educational Series

NIH Funding Educational Series

ASCO explores the decade-long decline in federal funding for cancer research – and why this decline must be reversed. Read more here.